Episode #3: The new GLP-1 kid on the block - Semaglutide!
Disgruntled Dan’s Conclusions: Semaglutide reduces the risk of nonfatal stroke (NNT 97 for 2.1 years), new or worsening nephropathy (NNT 43 over 2.1 y...
Disgruntled Dan's Pharmacy Podcast
Share:
Listens: 3
About
Evidence Based Medicine
Episode #3: The new GLP-1 kid on the block - Semaglutide!
Disgruntled Dan’s Conclusions: Semaglutide reduces the risk of nonfatal stroke (NNT 97 for 2.1 years), new or worsening nephropathy (NNT 43 over 2.1 y...
Episode #2: Pharmacist Awareness Month - The evidence for your family Pharmacist?
Disgruntled Dan’s Conclusions: Pharmacists in Alberta, Canada have one of the most advanced scopes of practice in the world. With this scope of practi...
Episode #2: Pharmacist Awareness Month - The evidence for your family Pharmacist?
Disgruntled Dan’s Conclusions: Pharmacists in Alberta, Canada have one of the most advanced scopes of practice in the world. With this scope of practi...
Episode #1: Shingrix - Too good to be true?
Disgruntled Dan's Conclusions 1) Shingrix – Reduces the incidence of Herpes Zoster Infections RRR of 97%; NNT of 36 over 3.7 years -Are the results t...
Episode #1: Shingrix - Too good to be true?
Disgruntled Dan's Conclusions 1) Shingrix – Reduces the incidence of Herpes Zoster Infections RRR of 97%; NNT of 36 over 3.7 years -Are the results t...